0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Blood Substitute Market Research Report 2026
Published Date: 2026-02-27
|
Report Code: QYRE-Auto-11P9275
Home | Market Reports | Health| Pharmacy
Global Artificial Blood Substitute Market Size Status and Forecast 2022
BUY CHAPTERS

Global Artificial Blood Substitute Market Research Report 2026

Code: QYRE-Auto-11P9275
Report
2026-02-27
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Artificial Blood Substitute Market Size

The global Artificial Blood Substitute market was valued at US$ 12.38 million in 2025 and is anticipated to reach US$ 59.14 million by 2032, at a CAGR of 25.4% from 2026 to 2032.

Artificial Blood Substitute Market

Artificial Blood Substitute Market

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.
The market for artificial blood substitutes is primarily driven by increasing medical demand and advancements in technology. On a global scale, the demand for blood transfusions continues to rise, while the availability of suitable blood is often constrained by challenges such as blood type compatibility, limited shelf life, and underdeveloped blood supply systems. Artificial blood substitutes can play a vital role in emergency care, mass casualty incidents, and battlefield medicine. In addition, the accelerating aging population, along with the growing number of major surgeries and trauma cases, has created strong clinical demand for safe, long-lasting, and universally compatible alternatives. Advances in bioengineering, nanotechnology, and synthetic biology are also fostering the development of more efficient and stable products. Furthermore, concerns over transfusion-related infections and low blood donation rates in certain regions are encouraging healthcare systems to prioritize artificial blood solutions, collectively driving market growth.
This report delivers a comprehensive overview of the global Artificial Blood Substitute market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artificial Blood Substitute. The Artificial Blood Substitute market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Artificial Blood Substitute market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Artificial Blood Substitute manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Artificial Blood Substitute Market Report

Report Metric Details
Report Name Artificial Blood Substitute Market
Accounted market size in 2025 US$ 12.38 million
Forecasted market size in 2032 US$ 59.14 million
CAGR 25.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • Hemoglobin-based Oxygen Carrier (HBOC)
Segment by Application
  • Military
  • Civil
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aurum Biosciences Ltd., Hemarina, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd., NuvOx Pharma, Safi Biotherapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Artificial Blood Substitute companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Artificial Blood Substitute Market growing?

Ans: The Artificial Blood Substitute Market witnessing a CAGR of 25.4% during the forecast period 2026-2032.

What is the Artificial Blood Substitute Market size in 2032?

Ans: The Artificial Blood Substitute Market size in 2032 will be US$ 59.14 million.

Who are the main players in the Artificial Blood Substitute Market report?

Ans: The main players in the Artificial Blood Substitute Market are Aurum Biosciences Ltd., Hemarina, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd., NuvOx Pharma, Safi Biotherapeutics

What are the Application segmentation covered in the Artificial Blood Substitute Market report?

Ans: The Applications covered in the Artificial Blood Substitute Market report are Military, Civil

What are the Type segmentation covered in the Artificial Blood Substitute Market report?

Ans: The Types covered in the Artificial Blood Substitute Market report are Perfluorocarbon-based Oxygen Carrier (PFBOC), Hemoglobin-based Oxygen Carrier (HBOC)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Blood Substitute Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
1.2.3 Hemoglobin-based Oxygen Carrier (HBOC)
1.3 Market by Application
1.3.1 Global Artificial Blood Substitute Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Military
1.3.3 Civil
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Blood Substitute Market Perspective (2021–2032)
2.2 Global Artificial Blood Substitute Growth Trends by Region
2.2.1 Global Artificial Blood Substitute Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Artificial Blood Substitute Historic Market Size by Region (2021–2026)
2.2.3 Artificial Blood Substitute Forecasted Market Size by Region (2027–2032)
2.3 Artificial Blood Substitute Market Dynamics
2.3.1 Artificial Blood Substitute Industry Trends
2.3.2 Artificial Blood Substitute Market Drivers
2.3.3 Artificial Blood Substitute Market Challenges
2.3.4 Artificial Blood Substitute Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Blood Substitute Players by Revenue
3.1.1 Global Top Artificial Blood Substitute Players by Revenue (2021–2026)
3.1.2 Global Artificial Blood Substitute Revenue Market Share by Players (2021–2026)
3.2 Global Top Artificial Blood Substitute Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Artificial Blood Substitute Revenue
3.4 Global Artificial Blood Substitute Market Concentration Ratio
3.4.1 Global Artificial Blood Substitute Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Blood Substitute Revenue in 2025
3.5 Global Key Players of Artificial Blood Substitute Head Offices and Areas Served
3.6 Global Key Players of Artificial Blood Substitute, Products and Applications
3.7 Global Key Players of Artificial Blood Substitute, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Artificial Blood Substitute Breakdown Data by Type
4.1 Global Artificial Blood Substitute Historic Market Size by Type (2021–2026)
4.2 Global Artificial Blood Substitute Forecasted Market Size by Type (2027–2032)
5 Artificial Blood Substitute Breakdown Data by Application
5.1 Global Artificial Blood Substitute Historic Market Size by Application (2021–2026)
5.2 Global Artificial Blood Substitute Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Artificial Blood Substitute Market Size (2021–2032)
6.2 North America Artificial Blood Substitute Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Artificial Blood Substitute Market Size by Country (2021–2026)
6.4 North America Artificial Blood Substitute Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Blood Substitute Market Size (2021–2032)
7.2 Europe Artificial Blood Substitute Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Artificial Blood Substitute Market Size by Country (2021–2026)
7.4 Europe Artificial Blood Substitute Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Artificial Blood Substitute Market Size (2021–2032)
8.2 Asia-Pacific Artificial Blood Substitute Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Artificial Blood Substitute Market Size by Region (2021–2026)
8.4 Asia-Pacific Artificial Blood Substitute Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Artificial Blood Substitute Market Size (2021–2032)
9.2 Latin America Artificial Blood Substitute Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Artificial Blood Substitute Market Size by Country (2021–2026)
9.4 Latin America Artificial Blood Substitute Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Blood Substitute Market Size (2021–2032)
10.2 Middle East & Africa Artificial Blood Substitute Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Artificial Blood Substitute Market Size by Country (2021–2026)
10.4 Middle East & Africa Artificial Blood Substitute Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aurum Biosciences Ltd.
11.1.1 Aurum Biosciences Ltd. Company Details
11.1.2 Aurum Biosciences Ltd. Business Overview
11.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Introduction
11.1.4 Aurum Biosciences Ltd. Revenue in Artificial Blood Substitute Business (2021–2026)
11.1.5 Aurum Biosciences Ltd. Recent Development
11.2 Hemarina
11.2.1 Hemarina Company Details
11.2.2 Hemarina Business Overview
11.2.3 Hemarina Artificial Blood Substitute Introduction
11.2.4 Hemarina Revenue in Artificial Blood Substitute Business (2021–2026)
11.2.5 Hemarina Recent Development
11.3 HbO2 Therapeutics
11.3.1 HbO2 Therapeutics Company Details
11.3.2 HbO2 Therapeutics Business Overview
11.3.3 HbO2 Therapeutics Artificial Blood Substitute Introduction
11.3.4 HbO2 Therapeutics Revenue in Artificial Blood Substitute Business (2021–2026)
11.3.5 HbO2 Therapeutics Recent Development
11.4 KaloCyte Inc.
11.4.1 KaloCyte Inc. Company Details
11.4.2 KaloCyte Inc. Business Overview
11.4.3 KaloCyte Inc. Artificial Blood Substitute Introduction
11.4.4 KaloCyte Inc. Revenue in Artificial Blood Substitute Business (2021–2026)
11.4.5 KaloCyte Inc. Recent Development
11.5 SpheriTech Ltd.
11.5.1 SpheriTech Ltd. Company Details
11.5.2 SpheriTech Ltd. Business Overview
11.5.3 SpheriTech Ltd. Artificial Blood Substitute Introduction
11.5.4 SpheriTech Ltd. Revenue in Artificial Blood Substitute Business (2021–2026)
11.5.5 SpheriTech Ltd. Recent Development
11.6 NuvOx Pharma
11.6.1 NuvOx Pharma Company Details
11.6.2 NuvOx Pharma Business Overview
11.6.3 NuvOx Pharma Artificial Blood Substitute Introduction
11.6.4 NuvOx Pharma Revenue in Artificial Blood Substitute Business (2021–2026)
11.6.5 NuvOx Pharma Recent Development
11.7 Safi Biotherapeutics
11.7.1 Safi Biotherapeutics Company Details
11.7.2 Safi Biotherapeutics Business Overview
11.7.3 Safi Biotherapeutics Artificial Blood Substitute Introduction
11.7.4 Safi Biotherapeutics Revenue in Artificial Blood Substitute Business (2021–2026)
11.7.5 Safi Biotherapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Artificial Blood Substitute Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Perfluorocarbon-based Oxygen Carrier (PFBOC)
 Table 3. Key Players of Hemoglobin-based Oxygen Carrier (HBOC)
 Table 4. Global Artificial Blood Substitute Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Artificial Blood Substitute Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Artificial Blood Substitute Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Artificial Blood Substitute Market Share by Region (2021–2026)
 Table 8. Global Artificial Blood Substitute Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Artificial Blood Substitute Market Share by Region (2027–2032)
 Table 10. Artificial Blood Substitute Market Trends
 Table 11. Artificial Blood Substitute Market Drivers
 Table 12. Artificial Blood Substitute Market Challenges
 Table 13. Artificial Blood Substitute Market Restraints
 Table 14. Global Artificial Blood Substitute Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Artificial Blood Substitute Market Share by Players (2021–2026)
 Table 16. Global Top Artificial Blood Substitute Players by Tier (Tier 1, Tier 2, and Tier 3), based on Artificial Blood Substitute Revenue, 2025
 Table 17. Ranking of Global Top Artificial Blood Substitute Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Artificial Blood Substitute Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Artificial Blood Substitute, Headquarters and Area Served
 Table 20. Global Key Players of Artificial Blood Substitute, Products and Applications
 Table 21. Global Key Players of Artificial Blood Substitute, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Artificial Blood Substitute Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Artificial Blood Substitute Revenue Market Share by Type (2021–2026)
 Table 25. Global Artificial Blood Substitute Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Artificial Blood Substitute Revenue Market Share by Type (2027–2032)
 Table 27. Global Artificial Blood Substitute Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Artificial Blood Substitute Revenue Market Share by Application (2021–2026)
 Table 29. Global Artificial Blood Substitute Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Artificial Blood Substitute Revenue Market Share by Application (2027–2032)
 Table 31. North America Artificial Blood Substitute Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Artificial Blood Substitute Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Artificial Blood Substitute Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Artificial Blood Substitute Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Artificial Blood Substitute Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Artificial Blood Substitute Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Artificial Blood Substitute Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Artificial Blood Substitute Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Artificial Blood Substitute Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Artificial Blood Substitute Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Artificial Blood Substitute Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Artificial Blood Substitute Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Artificial Blood Substitute Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Artificial Blood Substitute Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Artificial Blood Substitute Market Size by Country (US$ Million), 2027–2032
 Table 46. Aurum Biosciences Ltd. Company Details
 Table 47. Aurum Biosciences Ltd. Business Overview
 Table 48. Aurum Biosciences Ltd. Artificial Blood Substitute Product
 Table 49. Aurum Biosciences Ltd. Revenue in Artificial Blood Substitute Business (US$ Million), 2021–2026
 Table 50. Aurum Biosciences Ltd. Recent Development
 Table 51. Hemarina Company Details
 Table 52. Hemarina Business Overview
 Table 53. Hemarina Artificial Blood Substitute Product
 Table 54. Hemarina Revenue in Artificial Blood Substitute Business (US$ Million), 2021–2026
 Table 55. Hemarina Recent Development
 Table 56. HbO2 Therapeutics Company Details
 Table 57. HbO2 Therapeutics Business Overview
 Table 58. HbO2 Therapeutics Artificial Blood Substitute Product
 Table 59. HbO2 Therapeutics Revenue in Artificial Blood Substitute Business (US$ Million), 2021–2026
 Table 60. HbO2 Therapeutics Recent Development
 Table 61. KaloCyte Inc. Company Details
 Table 62. KaloCyte Inc. Business Overview
 Table 63. KaloCyte Inc. Artificial Blood Substitute Product
 Table 64. KaloCyte Inc. Revenue in Artificial Blood Substitute Business (US$ Million), 2021–2026
 Table 65. KaloCyte Inc. Recent Development
 Table 66. SpheriTech Ltd. Company Details
 Table 67. SpheriTech Ltd. Business Overview
 Table 68. SpheriTech Ltd. Artificial Blood Substitute Product
 Table 69. SpheriTech Ltd. Revenue in Artificial Blood Substitute Business (US$ Million), 2021–2026
 Table 70. SpheriTech Ltd. Recent Development
 Table 71. NuvOx Pharma Company Details
 Table 72. NuvOx Pharma Business Overview
 Table 73. NuvOx Pharma Artificial Blood Substitute Product
 Table 74. NuvOx Pharma Revenue in Artificial Blood Substitute Business (US$ Million), 2021–2026
 Table 75. NuvOx Pharma Recent Development
 Table 76. Safi Biotherapeutics Company Details
 Table 77. Safi Biotherapeutics Business Overview
 Table 78. Safi Biotherapeutics Artificial Blood Substitute Product
 Table 79. Safi Biotherapeutics Revenue in Artificial Blood Substitute Business (US$ Million), 2021–2026
 Table 80. Safi Biotherapeutics Recent Development
 Table 81. Research Programs/Design for This Report
 Table 82. Key Data Information from Secondary Sources
 Table 83. Key Data Information from Primary Sources
 Table 84. Authors List of This Report


List of Figures
 Figure 1. Artificial Blood Substitute Picture
 Figure 2. Global Artificial Blood Substitute Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Artificial Blood Substitute Market Share by Type: 2025 vs 2032
 Figure 4. Perfluorocarbon-based Oxygen Carrier (PFBOC) Features
 Figure 5. Hemoglobin-based Oxygen Carrier (HBOC) Features
 Figure 6. Global Artificial Blood Substitute Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Artificial Blood Substitute Market Share by Application: 2025 vs 2032
 Figure 8. Military Case Studies
 Figure 9. Civil Case Studies
 Figure 10. Artificial Blood Substitute Report Years Considered
 Figure 11. Global Artificial Blood Substitute Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 12. Global Artificial Blood Substitute Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Artificial Blood Substitute Market Share by Region: 2025 vs 2032
 Figure 14. Global Artificial Blood Substitute Market Share by Players in 2025
 Figure 15. Global Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by Artificial Blood Substitute Revenue in 2025
 Figure 17. North America Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 18. North America Artificial Blood Substitute Market Share by Country (2021–2032)
 Figure 19. United States Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. Canada Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Europe Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Artificial Blood Substitute Market Share by Country (2021–2032)
 Figure 23. Germany Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. France Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. U.K. Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Italy Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Russia Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Ireland Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Asia-Pacific Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Artificial Blood Substitute Market Share by Region (2021–2032)
 Figure 31. China Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Japan Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. South Korea Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Southeast Asia Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. India Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Australia & New Zealand Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Latin America Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Artificial Blood Substitute Market Share by Country (2021–2032)
 Figure 39. Mexico Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Brazil Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Middle East & Africa Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Artificial Blood Substitute Market Share by Country (2021–2032)
 Figure 43. Israel Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Saudi Arabia Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. UAE Artificial Blood Substitute Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Aurum Biosciences Ltd. Revenue Growth Rate in Artificial Blood Substitute Business (2021–2026)
 Figure 47. Hemarina Revenue Growth Rate in Artificial Blood Substitute Business (2021–2026)
 Figure 48. HbO2 Therapeutics Revenue Growth Rate in Artificial Blood Substitute Business (2021–2026)
 Figure 49. KaloCyte Inc. Revenue Growth Rate in Artificial Blood Substitute Business (2021–2026)
 Figure 50. SpheriTech Ltd. Revenue Growth Rate in Artificial Blood Substitute Business (2021–2026)
 Figure 51. NuvOx Pharma Revenue Growth Rate in Artificial Blood Substitute Business (2021–2026)
 Figure 52. Safi Biotherapeutics Revenue Growth Rate in Artificial Blood Substitute Business (2021–2026)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS